Back to Search
NAOMI WINICK, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1568422731Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
G7025(TX)
Research & Publications (20)
Is immunization necessary after therapy for acute lymphoblastic leukemia (ALL) has been completed?
PMID 19653293·Pediatr Blood Cancer·2009
8-other
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
PMID 18818707·Leukemia·2008
8-other
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
PMID 18711187·J Clin Oncol·2008
2-rct
Risk factors for readmission after initial diagnosis in children with acute lymphoblastic leukemia.
PMID 18393271·Pediatr Blood Cancer·2008
8-other
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
PMID 18388178·Blood·2008
8-other
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18182569·Blood·2008
8-other
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
PMID 17644914·J Neurosurg·2007
8-other
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
PMID 17003380·Blood·2007
4-observational
Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
PMID 16809737·J Clin Oncol·2006
3-trial
Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
PMID 16184615·Cytometry B Clin Cytom·2005
4-observational
Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough?
PMID 16007585·Pediatr Blood Cancer·2005
4-observational
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.
PMID 15169924·Pharmacol Rev·2004
8-other
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
PMID 15459213·J Clin Oncol·2004
3-trial
Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.
PMID 15167354·J Pediatr Hematol Oncol·2004
5-case
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
PMID 15084615·J Clin Oncol·2004
3-trial
Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.
PMID 14752800·Pediatr Blood Cancer·2004
3-trial
Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
PMID 12885817·J Clin Oncol·2003
8-other
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
PMID 12439220·Pharmacogenetics·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 730-5437
Quick Facts
- NPI
- 1568422731
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile